#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13374	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2094	632.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1395	1395	C	784	C,T	754,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13374	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2094	632.8	0	HET	.	.	.	C451T	.	451	451	C	662	662	C	776	C,T	400,358	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	762	C,T	741,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	1967	1967	G	750	G,A	545,185	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	733	C,A	703,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	758	A	735	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	703	C	685	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24302	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3499	689.9	0	HET	.	.	.	G1571A	.	1571	1571	G	1900	1900	G	757	G,A	562,163	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	155	172	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1306	13.0	0	HET	.	.	.	T539C	.	539	539	T	736	736	T	20	T,C	11,9	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1648	folP	855	855	100.0	folP.l6.c17.ctg.1	1463	111.9	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	159;159;159	A;G;C	153;154;153	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	139.7	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	150;150;151	T;T;C	147;146;147	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	139.7	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	151;150;150	G;G,T;C,T	144;141,1;143,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	139.7	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	151;150;150	G;G,T;C,T	144;141,1;143,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1530	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1349	112.2	1	SNP	p	G45D	0	.	.	133	135	GGC	444	446	GGC	201;199;198	G;G;C	199;193;198	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	788	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	965	81.1	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	169	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4606	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2922	156.7	1	SNP	p	D86N	0	.	.	256	258	GAC	534	536	GAC	171;170;173	G;A;C	166;161;168	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4606	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2922	156.7	1	SNP	p	S87R	1	.	.	259	261	CGT	537	539	CGT	170;172;170	C;G;T,C	166;165;158,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4606	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2922	156.7	1	SNP	p	R87I	0	.	.	259	261	CGT	537	539	CGT	170;172;170	C;G;T,C	166;165;158,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4606	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2922	156.7	1	SNP	p	R87W	0	.	.	259	261	CGT	537	539	CGT	170;172;170	C;G;T,C	166;165;158,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4606	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2922	156.7	1	SNP	p	S88P	0	.	.	262	264	TCC	540	542	TCC	172;173;173	T;C,A;C	167;166,1;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3672	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2515	144.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	204;203;204	G;G;C	191;191;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1282	1284	GCC	175;172;170	G;C,T;C	164;163,1;163	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1285	1287	ATG	168;169;168	A;T;G	162;161;159	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1297	1299	ACC	173;174;173	A;C;C	165;165;162	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1297	1299	ACC	173;174;173	A;C;C	165;165;162	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1798	1800	ACC	175;175;178	A;C;C	168;172;175	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1852	1854	GCG	171;169;169	G;C;G	164;161;160	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1852	1854	GCG	171;169;169	G;C;G	164;161;160	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1975	1977	GGT	136;135;135	G;G;T	132;130;128	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1984	1986	AGC	118;119;117	A;G;C	114;113;112	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3412	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2402	140.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2002	2004	CCG	97;100;100	C,G;C;G	89,1;94;89	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5134	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3067	166.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1590	1592	CCG	206;203;203	C;C;G,A,C	188;195;193,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2302	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1775	128.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	542	542	C	158	C,G,A	148,1,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	121	123	AAT	16;17;17	A;A;T	16;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	124	126	AAT	17;17;17	A;A;T	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	148	150	GCA	18;18;18	G;C;A	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	171	173	GTA	18;18;18	G;T;A	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	W235trunc	TRUNC	703	703	T	174	174	T	17	T	17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	280	porB1a	984	267	90.04	porB1a.l6.c30.ctg.2	363	23.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	180	180	A	17	A	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	958	960	AGA	223;222;221	A;G;A	211;207;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	979	981	GGT	223;226;225	G,A;G;T,C,A	216,1;222;217,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1084	1086	GAA	202;201;203	G;A,G;A	199;196,2;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	1	SNP	p	G120K	1	.	.	358	360	AAG	688	690	AAG	206;205;205	A;A;G,A	199;200;194,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	1	SNP	p	A121N	1	.	.	361	363	AAC	691	693	AAC	206;204;204	A;A;C	203;201;197	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2602	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1495	171.7	1	SNP	p	N121D	0	.	.	361	363	AAC	691	693	AAC	206;204;204	A;A;C	203;201;197	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8972	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4938	180.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1046	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	983	105.9	1	SNP	p	V57M	1	.	.	169	171	ATG	508	510	ATG	209;208;212	A;T;G	204;202;207	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	28	tetM	1920	275	99.27	tetM.l15.c30.ctg.1	344	2.6	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	21	23	ACC	1;1;1	A;C;C	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	28	tetM	1920	275	99.27	tetM.l15.c30.ctg.1	344	2.6	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	117	119	GAA	2;2;2	G;A;A	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	28	tetM	1920	128	99.22	tetM.l15.c30.ctg.2	303	2.2	0	.	p	.	0	K2I	NONSYN	4	6	AAA	179	181	ATA	3;3;3	A;T,A;A	3;0,3;3	.	Tetracycline resistance
